Decorative image for Follow Our Progress page banner

Follow Our Progress

事件

Safety, Biomarker Responses, and Preliminary Efficacy Following a Single Intrathecal Dose of RAG-17, a Novel siRNA Therapeutic for SOD1-ALS: Results from an Ongoing Phase I/II Study（海报）

By April 19, 2026June 8th, 2026No Comments
新闻与事件
04/19/26

Safety, Biomarker Responses, and Preliminary Efficacy Following a Single Intrathecal Dose of RAG-17, a Novel siRNA Therapeutic for SOD1-ALS: Results from an Ongoing Phase I/II Study（海报）